BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35972537)

  • 1. Histopathology and molecular pathology of pediatric pineal parenchymal tumors.
    Vasiljevic A
    Childs Nerv Syst; 2023 Sep; 39(9):2273-2284. PubMed ID: 35972537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
    Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
    Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study.
    Li BK; Vasiljevic A; Dufour C; Yao F; Ho BLB; Lu M; Hwang EI; Gururangan S; Hansford JR; Fouladi M; Nobusawa S; Laquerriere A; Delisle MB; Fangusaro J; Forest F; Toledano H; Solano-Paez P; Leary S; Birks D; Hoffman LM; Szathmari A; Faure-Conter C; Fan X; Catchpoole D; Zhou L; Schultz KAP; Ichimura K; Gauchotte G; Jabado N; Jones C; Loussouarn D; Mokhtari K; Rousseau A; Ziegler DS; Tanaka S; Pomeroy SL; Gajjar A; Ramaswamy V; Hawkins C; Grundy RG; Hill DA; Bouffet E; Huang A; Jouvet A
    Acta Neuropathol; 2020 Feb; 139(2):223-241. PubMed ID: 31820118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations.
    Pfaff E; Aichmüller C; Sill M; Stichel D; Snuderl M; Karajannis MA; Schuhmann MU; Schittenhelm J; Hasselblatt M; Thomas C; Korshunov A; Rhizova M; Wittmann A; Kaufhold A; Iskar M; Ketteler P; Lohmann D; Orr BA; Ellison DW; von Hoff K; Mynarek M; Rutkowski S; Sahm F; von Deimling A; Lichter P; Kool M; Zapatka M; Pfister SM; Jones DTW
    Acta Neuropathol; 2020 Feb; 139(2):243-257. PubMed ID: 31768671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
    Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA
    Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
    Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
    World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials.
    Liu APY; Gudenas B; Lin T; Orr BA; Klimo P; Kumar R; Bouffet E; Gururangan S; Crawford JR; Kellie SJ; Chintagumpala M; Fisher MJ; Bowers DC; Hassall T; Indelicato DJ; Onar-Thomas A; Ellison DW; Boop FA; Merchant TE; Robinson GW; Northcott PA; Gajjar A
    Acta Neuropathol; 2020 Feb; 139(2):259-271. PubMed ID: 31802236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.
    Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R
    Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pineal Parenchymal Tumor of Intermediate Differentiation and DICER1 Syndrome: A Case Report.
    Gupte A; Sood S; Kupsky WJ; Altinok D; Miller S; Roy S; Bhambhani K
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e406-e409. PubMed ID: 36044309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8.
    de Kock L; Rivera B; Foulkes WD
    Acta Neuropathol; 2020 Jun; 139(6):1115-1118. PubMed ID: 32124011
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
    Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
    Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging based morphologic evaluation of the pineal gland for suspected pineoblastoma in retinoblastoma patients and age-matched controls.
    Pham TT; Siebert E; Asbach P; Willerding G; Erb-Eigner K
    J Neurol Sci; 2015 Dec; 359(1-2):185-92. PubMed ID: 26671110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pathogenic variant of
    Rivera-Hernández A; Madrigal-González M; Mejía-Carmona L; Martínez-López I; Pérez-Hernández MG; Bernal-Manjarrez J; Luna-Vidal S; Reta-Guerrero S; Rodríguez-Florido MA; Balcázar-Hernández L
    J Pediatr Endocrinol Metab; 2023 Aug; 36(8):782-785. PubMed ID: 37307239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
    Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
    Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
    Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
    Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign and Malignant Tumors of the Pineal Region.
    Upadhyayula PS; Neira JA; Miller ML; Bruce JN
    Adv Exp Med Biol; 2023; 1405():153-173. PubMed ID: 37452938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathology of pineal parenchymal tumors.
    Sato K; Kubota T
    Prog Neurol Surg; 2009; 23():12-25. PubMed ID: 19329858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pineal parenchymal tumours and pineal cysts.
    Jouvet A; Vasiljevic A; Champier J; Fèvre Montange M
    Neurochirurgie; 2015; 61(2-3):123-9. PubMed ID: 24975206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A temporal in vivo catalog of chromatin accessibility and expression profiles in pineoblastoma reveals a prevalent role for repressor elements.
    Idriss S; Hallal M; El-Kurdi A; Zalzali H; El-Rassi I; Ehli EA; Davis CM; Chung PED; Gendoo DMA; Zacksenhaus E; Saab R; Khoueiry P
    Genome Res; 2023 Feb; 33(2):269-282. PubMed ID: 36650051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma.
    Snuderl M; Kannan K; Pfaff E; Wang S; Stafford JM; Serrano J; Heguy A; Ray K; Faustin A; Aminova O; Dolgalev I; Stapleton SL; Zagzag D; Chiriboga L; Gardner SL; Wisoff JH; Golfinos JG; Capper D; Hovestadt V; Rosenblum MK; Placantonakis DG; LeBoeuf SE; Papagiannakopoulos TY; Chavez L; Ahsan S; Eberhart CG; Pfister SM; Jones DTW; Karajannis MA
    Nat Commun; 2018 Jul; 9(1):2868. PubMed ID: 30030436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.